Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NANP | Q8TBE9 | 3/20 | 0.42 |
| ▸ | NEU3 | Q9UQ49 | 3/20 | 0.41 |
| ▸ | NEU1 | Q99519 | 7/20 | 0.39 |
| ▸ | NEU2 | Q9Y3R4 | 6/20 | 0.39 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.39 |
| ▸ | CD22 | P20273 | 3/20 | 0.37 |
| ▸ | MAG | P20916 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12778459 | 1.00 | L3MBTL1 (0.44) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL23640153 | 0.91 | L3MBTL1 (0.46) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL26774721 | 0.89 | L3MBTL1 (0.44) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL20306037 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL13895451 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL23635227 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL13895438 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL23640238 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL2742891 | 0.87 | NANP (0.54) | L3MBTL1NANPNEU3NEU1NEU2 | |
| SCHEMBL12361497 | 0.85 | L3MBTL1 (0.59) | L3MBTL1NANPNEU3NEU1NEU2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2305312-B1 | Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) | RATIOPHARM GMBH (DE) | 2015-03-04 | — | — | EP | disclosed |